Neurol. praxi. 2021;22(4):260-263 | DOI: 10.36290/neu.2021.004

Community-acquired bacterial meningitis

doc. MUDr. Olga Džupová, Ph.D.
3. lékařská fakulta Univerzity Karlovy, Klinika infekčních nemocí, Nemocnice Na Bulovce, Praha

Purulent infections of the central nervous system belong to life-threatening diseases. Their incidence is relatively low; however, their importance lies in high case fatality ratio and frequent permanent sequelae. The prognosis depends on a number of factors, most notably the speed of diagnosis and the initiation of correct causal and supportive treatment. Therefore, it is necessary to educate physicians of all disciplines about the importance and approach to these infections. Purulent meningitis is an infection of the soft meninges caused by pyogenic bacteria. Despite declining incidence over the last 20 years and medical progress, due to its high case fatality ratio and permanent sequelae meningitis remains a major challenge for physicians and scientists.

Keywords: acute bacterial meningitis, epidemiology, diagnostics, treatment, complication.

Accepted: January 6, 2021; Published: September 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Džupová O. Community-acquired bacterial meningitis. Neurol. praxi. 2021;22(4):260-263. doi: 10.36290/neu.2021.004.
Download citation

References

  1. Alari A, Chaussade H, Domenech De Celles M, Le Fouler L, Varon E, Opatowski L, Guillemot D, Watier L. Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis. BMC Med. 2016; 14: 211. Go to original source... Go to PubMed...
  2. Brouwer MC, van de Beek D. Epidemiology of community-acquired meningitis. Curr Opin Infect Dis. 2018; 31: 78-84. Go to original source... Go to PubMed...
  3. Campbell H, Edelstein M, Andrews N, Borrow R, Ramsay M, Ladhani S. Emergency meningococcal ACWY vaccination program for teenagers to control group W meningococcal disease, England, 2015-2016. Emerg Infect Dis. 2017; 23: 1184-1187. Go to original source... Go to PubMed...
  4. Costerus JM, Brouwer MC, Sprengers MES, Roosendaal SD, van der Ende A, van de Beek D. Cranial computed tomography, lumbar puncture, and clinical deterioration in bacterial meningitis: a nationwide cohort study. Clin Infect Dis. 2018; 67: 920-926. Go to original source... Go to PubMed...
  5. Džupová O, Helcl M, Kračmarová R, Krbková L, Pařízková R, Rožnovský L. Doporučený postup diagnostiky a léčby purulentní meningitidy. Klin Mikrobiol Infekc Lek. 2017; 23: 76-84. Go to PubMed...
  6. Figueiredo AHA, Brouwer MC, van de Beek D. Acute community-acquired meningitis. Neurol Clin. 2018; 36: 809-820. Go to original source... Go to PubMed...
  7. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009; 360: 244-256. Go to original source... Go to PubMed...
  8. Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Infect. 2016; 73: 18-27. Go to original source... Go to PubMed...
  9. Olarte L, Barson WJ, Barson RM, Ling Lin P, Romero JR, Tan TQ, Givner LB, Bradley JS, Hoffman JA, Hultén KG, Mason EO, Kaplan SL. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clin Infect Dis. 2015; 61: 767-775. Go to original source... Go to PubMed...
  10. Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Préziosi MP, Stuart JM. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data. Lancet Infect Dis. 2017; 17: 867-872. Go to original source... Go to PubMed...
  11. van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, Pfister HW, Read RC, Resat Sipahi O, Brouwer MC. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016; 22: S37-62. Go to original source... Go to PubMed...
  12. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004; 351: 1849-1859. Go to original source... Go to PubMed...
  13. Whitaker R, Dias JG, Ramliden M, Kodmon C, Economopoulou A, Beer N, Pastore Celentano L. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Vaccine. 2017; 35: 2034-2041. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.